We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+0.28%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$360B
AUM Growth
-$5.05B
Cap. Flow
-$2.61B
Cap. Flow %
-0.72%
Top 10 Hldgs %
13.81%
Holding
6,930
New
170
Increased
3,227
Reduced
2,806
Closed
155

Sector Composition

Rank Sector Weight
1 Technology 11.4%
2 Financials 10.07%
3 Consumer Discretionary 8.39%
4 Healthcare 7.69%
5 Communication Services 6.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CASM
6276
DELISTED
CAS Medical Systems, Inc.
CASM
$3K ﹤0.01%
2,378
+1,657
+230% +$1.87K
HMTA
6277
DELISTED
HomeTown Bankshares Corporation Common Stock
HMTA
$3K ﹤0.01%
229
HQCL
6278
DELISTED
Hanwha Q CELLS Co., Ltd.
HQCL
$3K ﹤0.01%
331
-135
-29% -$1.04K
SNMX
6279
DELISTED
Senomyx, Inc.
SNMX
$3K ﹤0.01%
3,097
-93
-3% -$111
STDY
6280
DELISTED
SteadyMed Ltd
STDY
$3K ﹤0.01%
1,000
JJM
6281
DELISTED
iPath Bloomberg Industrial Metals Subindex Total Return ETN due October 22, 2037
JJM
$3K ﹤0.01%
106
SDR
6282
DELISTED
SANDRIDGE MISSISSIPPIAN TRUST II
SDR
$3K ﹤0.01%
3,175
-2,615
-45% -$2.56K
SZO
6283
DELISTED
DB Crude Oil Short Exchange Traded Notes due June 1, 2038
SZO
$3K ﹤0.01%
50
OREX
6284
DELISTED
Orexigen Therapeutics, Inc.
OREX
$3K ﹤0.01%
15,319
+4,944
+48% +$4.56K
PTM
6285
DELISTED
E-TRACS UBS Long Platinum ETN
PTM
$3K ﹤0.01%
352
BAL
6286
DELISTED
iPath Bloomberg Cotton Subindex Total Return ETN due June 24, 2038
BAL
$3K ﹤0.01%
50
-89
-64% -$4.74K
ICI
6287
DELISTED
iPath Optimized Currency Carry ETN
ICI
$3K ﹤0.01%
+87
New +$3.22K
ATLC icon
6288
Atlanticus Holdings
ATLC
$1.6B
$2K ﹤0.01%
1,150
BWEN icon
6289
Broadwind
BWEN
$91.3M
$2K ﹤0.01%
1,043
-1,306
-56% -$3.18K
PRHI
6290
Presurance Holdings
PRHI
$18.7M
$2K ﹤0.01%
59
GEVO icon
6291
Gevo
GEVO
$372M
$2K ﹤0.01%
256
-1
-0.4% -$10
AGIG
6292
Abundia Global Impact Group
AGIG
$41.4M
$2K ﹤0.01%
40
IMNN icon
6293
Imunon
IMNN
$6.72M
$2K ﹤0.01%
5
INTG icon
6294
InterGroup Corp
INTG
$59M
$2K ﹤0.01%
101
IPWR icon
6295
Ideal Power
IPWR
$60.9M
$2K ﹤0.01%
200
IVAL icon
6296
Alpha Architect International Quantitative Value ETF
IVAL
$225M
$2K ﹤0.01%
65
SDEV
6297
Stablecoin Development Corp
SDEV
$32M
0
PRPL icon
6298
Purple Innovation
PRPL
$31.6M
$2K ﹤0.01%
+10
New +$2.59K
PZG icon
6299
Paramount Gold Nevada
PZG
$99.5M
$2K ﹤0.01%
1,363
RAVE icon
6300
RAVE Restaurant Group
RAVE
$44.1M
$2K ﹤0.01%
1,500
-1,000
-40% -$1.55K

Similar funds

Morgan Stanley's Q1 2018 Portfolio in Review

As of Q1 2018, Morgan Stanley held 6,930 positions worth $360B, down 1.4% from $365B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Trading was light in Q1 2018: portfolio turnover was 4.7%. Morgan Stanley opened 170 new positions and exited 155, leaving the 6,930-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Morgan Stanley's largest Q1 2018 buy was Nutrien: 1,554,481 shares worth $73.5M.
  • Morgan Stanley added most to iShares Russell 2000 ETF in Q1 2018, an estimated $1.27B increase.
  • Morgan Stanley's biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.33B.
  • Morgan Stanley fully exited Juno Therapeutics, Inc. in Q1 2018, selling an estimated $86M.
  • Morgan Stanley's ten largest holdings make up 14% of its $360B portfolio in Q1 2018.
  • Morgan Stanley opened 170 new positions and closed 155 in Q1 2018.
  • Morgan Stanley's portfolio value fell 1.4% quarter-over-quarter to $360B.

Based on Morgan Stanley's 13F filing for Q1 2018, filed 14 May 2018.